Workflow
DISCO Study Highlights Rapid Pace of Legal Generative AI Adoption, Key Barriers for Lawyers
Businesswire· 2025-10-30 12:46
Oct 30, 2025 8:46 AM Eastern Daylight Time DISCO Study Highlights Rapid Pace of Legal Generative AI Adoption, Key Barriers for Lawyers Share Data shows 72 percent expect to incorporate GenAI tools in the next 12 months or sooner AUSTIN, Texas--(BUSINESS WIRE)--Generative AI is rapidly reshaping the legal technology landscape – particularly in eDiscovery – and law firms and corporations are feeling increasing pressure to consider Gen AI solutions as workloads and litigation complexity increases. That's accor ...
House of Doge - The Official Corporate Arm of the Dogecoin Foundation, and Merger Partner Brag House Holdings Confirm Triestina Sponsorship with Dogecoin as Primary Kit and Stadium Mark
Globenewswire· 2025-10-30 12:45
NEW YORK and MIAMI, Oct. 30, 2025 (GLOBE NEWSWIRE) -- House of Doge Inc., the official corporate arm of the Dogecoin Foundation, together with merger partner Brag House Holdings, Inc. (NASDAQ: TBH), and U.S. Triestina Calcio 1918, today announced a multi-asset sponsorship that places Dogecoin front-and-center on the club’s official match jerseys, with House of Doge featured on select secondary placements. The announcement follows House of Doge’s recent equity acquisition of Triestina, which made history as ...
Cycurion Launches Strategic Cybersecurity Webinar Series to Fortify Public Sector Defenses
Globenewswire· 2025-10-30 12:45
MCLEAN, Va., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. ("Cycurion" or the "Company") (NASDAQ: CYCU), a publicly traded leader in technology and staffing solutions for the public sector, today announces a comprehensive cybersecurity education initiative with the National Association of County and City Health Officials (NACCHO) designed to empower healthcare organizations with critical threat intelligence and defensive strategies. The three-part webinar series, featuring industry expert Eric Singleton, ...
SurgePays Unlocks New Revenue Channel with Launch of Growth Marketing & Data Partnerships Division
Globenewswire· 2025-10-30 12:45
New initiative, led by industry veteran James Herber, accelerates monetization of SurgePays’ data ecosystem and expands high-margin recurring revenue opportunitiesMEMPHIS, Tenn., Oct. 30, 2025 (GLOBE NEWSWIRE) -- SurgePays, Inc. (NASDAQ: SURG), a wireless and fintech technology company connecting underserved consumers to essential mobile and financial services, today announced the launch of its new Growth Marketing and Data Partnerships Division. The initiative marks a significant step in SurgePays’ strateg ...
Moleculin to Highlight its Ongoing Phase 3 Acute Myeloid Leukemia “MIRACLE” Clinical Trial at the 14th Annual Acute Leukemia Meeting
Globenewswire· 2025-10-30 12:40
Core Viewpoint - Moleculin Biotech, Inc. is advancing its lead program Annamycin, a non-cardiotoxic anthracycline, through a pivotal Phase 3 trial for treating relapsed or refractory acute myeloid leukemia (AML) [1][4] Company Overview - Moleculin Biotech, Inc. is a late-stage pharmaceutical company focused on developing drug candidates for hard-to-treat cancers and viral infections [1][3] - The company’s lead candidate, Annamycin, is designed to avoid multidrug resistance mechanisms and lacks the cardiotoxicity associated with current anthracyclines [3] Clinical Trials - The ongoing MIRACLE trial is a Phase 2B/3, multi-center, randomized, double-blind, placebo-controlled study evaluating Annamycin in combination with cytarabine for adult patients with R/R AML [1][4] - Annamycin has received Fast Track Status and Orphan Drug Designation from the FDA for R/R AML and STS lung metastases, as well as Orphan Drug Designation from the EMA [2] Upcoming Presentation - Dr. Paul Waymack, Senior Chief Medical Officer, will present details of the MIRACLE trial at the 14th Annual Acute Leukemia Meeting on October 30, 2025 [1]
NanoXplore Closes Bought Deal Life Private Placement of $25,728,840
Globenewswire· 2025-10-30 12:38
Core Viewpoint - NanoXplore Inc. has successfully closed a bought deal private placement, issuing 10,720,350 common shares at a price of $2.40 per share, resulting in gross proceeds of $25,728,840 [1][2]. Group 1: Offering Details - The offering was led by a syndicate of underwriters, including Ventum Financial Corp. and Cormark Securities Inc., along with National Bank Financial Inc., RBC Dominion Securities Inc., Paradigm Capital Inc., and Raymond James Ltd. [2] - The net proceeds from the offering will be utilized for future growth, specifically in dry graphene expansion, as well as for general corporate and working capital purposes [2]. - The offering was completed under the "listed issuer financing" exemption, allowing the common shares to be freely tradeable without a hold period under Canadian securities laws [3]. Group 2: Insider Participation - Martinrea International Inc., an insider of the Corporation, subscribed for 2,343,750 common shares, amounting to approximately $5,625,000, thereby maintaining its interest in NanoXplore [4]. - The insider's participation is classified as a "related party transaction," and the Corporation relied on exemptions from formal valuation and minority shareholder approval requirements [5]. Group 3: Company Overview - NanoXplore is a leading graphene company that manufactures and supplies high-volume graphene powder for various industrial applications, including transportation and electronics [8]. - The Corporation also produces silicon-graphene-enhanced Li-ion batteries for electric vehicles and grid storage markets, with manufacturing facilities located in Canada, the United States, and Europe [8].
Akari Therapeutics Announces Formation of Scientific Advisory Board and Inaugural Appointment of Renowned Medical Oncologist, Sara A. Hurvitz, MD, FACP
Globenewswire· 2025-10-30 12:35
Dr. Hurvitz is an international expert in oncology and a recognized clinical research leader with extensive experience leading clinical trials spanning all phasesBOSTON and LONDON, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced the formation of its Scientific Advisory Board (SAB) and inaugural appointment of Dr. Sara Hurvitz. “The formation of our SAB marks an important step ...
Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence
Globenewswire· 2025-10-30 12:32
New collaboration provides services to streamline patient support, reduce administrative burden, and expand access to advanced TMS treatment across Elite DNA ClinicsMALVERN, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced an exclusive three-year agreement with Elite DNA Behavioral Health, one of Flo ...
Banzai to Host Third Quarter 2025 Financial Results Conference Call on Friday, November 14, 2025 at 4:30 p.m. Eastern Time
Globenewswire· 2025-10-30 12:31
Core Viewpoint - Banzai International, Inc. will hold a conference call on November 14, 2025, to discuss its third-quarter financial results and ongoing initiatives [1][2]. Company Overview - Banzai is a marketing technology company that offers AI-enabled marketing and sales solutions for businesses of all sizes, aiming to help customers grow by effectively targeting, engaging, and measuring both new and existing customers [3]. - The company has over 140,000 customers, including notable names such as RBC, Dell Technologies, and New York Life [3]. Conference Call Details - The conference call will be hosted by Founder & CEO Joe Davy and CFO Dean Ditto, followed by a Q&A session [2]. - The call is scheduled for November 14, 2025, at 4:30 p.m. Eastern Time, with a webcast available for viewing [2].
Worksport Announces Official Launch Date for SOLIS and COR Clean Energy Products
Globenewswire· 2025-10-30 12:31
Core Insights - Worksport Ltd. officially launches its SOLIS Solar Tonneau Cover and COR Portable Energy Storage System on November 28, 2025, marking a significant step into clean energy solutions [1][2] Product Launch and Pricing Details - The COR Starter Kit (Inverter + Battery) will be priced at $949, with the option to purchase additional batteries, while the SOLIS Solar Tonneau System will start at $1,999 [2] - The COR system can operate independently or in conjunction with the SOLIS solar array to create a portable, modular nano-grid for renewable energy [2] Revenue Potential and Strategic Impact - The initial rollout aims to deliver 1,000 COR units and 900 additional 1kWh battery packs, alongside a limited number of SOLIS solar tonneau covers, representing an initial revenue opportunity of approximately $2.45 million [4] - The company plans to scale production rapidly throughout 2026, targeting significant additional revenue [4] Market Expansion and Competitive Edge - The launch of SOLIS and COR broadens Worksport's customer demographics and market footprint, introducing a unique solar-powered ecosystem with no direct competition in the vehicle accessory market [6] - The tonneau cover business has shown explosive growth, increasing from $1.5 million in 2023 to an expected $24 million run rate by the end of 2025, with projections to exceed $100 million within two years [7] Product Validation and Performance - The COR portable power system has been validated through multiple performance tests, demonstrating its capability to power heavy industrial equipment in extreme conditions [8] - When paired with the SOLIS solar cover, the system forms a self-sustaining, portable nano-grid that can recharge faster than it discharges [8] Leadership Commentary - The CEO of Worksport emphasizes that the launch marks a new chapter for the company, integrating renewable power into the lifestyles of truck owners and clean-tech enthusiasts [9][10] Forward Outlook - The commercialization of SOLIS and COR is expected to accelerate Worksport's path to profitability and establish its position as a rising leader in the U.S. clean-tech sector [11] - Future plans include expanding the COR system into home and commercial applications, as well as adaptations for various industries [11]